US FDA and big pharma to shorten TB drug development times
This article was originally published in Scrip
Executive Summary
The US FDA and 10 pharmaceutical companies are to take part in a new initiative to speed up drug development of new combinations of tuberculosis treatments, which is hoped could cut the development times from 25 to six years.